Abstract 1992: Serine hydroxymethyltransferase-2 as regulator of oxidative stress and chemoradiation resistance in lung adenocarcinoma

Author(s):  
Kunal R. Chaudhary ◽  
Connor J. Kinslow ◽  
Ling F. Ye ◽  
Pavan S. Upadhyayula ◽  
Eun Y. Lee ◽  
...  
2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Yi-Hua Jan ◽  
Tsung-Ching Lai ◽  
Chih-Jen Yang ◽  
Yuan-Feng Lin ◽  
Ming-Shyan Huang ◽  
...  

2020 ◽  
Vol 11 (11) ◽  
Author(s):  
Amani Bouzidi ◽  
Maria Chiara Magnifico ◽  
Alessandro Paiardini ◽  
Alberto Macone ◽  
Giovanna Boumis ◽  
...  

AbstractNutrient utilization and reshaping of metabolism in cancer cells is a well-known driver of malignant transformation. Less clear is the influence of the local microenvironment on metastasis formation and choice of the final organ to invade. Here we show that the level of the amino acid serine in the cytosol affects the migratory properties of lung adenocarcinoma (LUAD) cells. Inhibition of serine or glycine uptake from the extracellular milieu, as well as knockdown of the cytosolic one-carbon metabolism enzyme serine hydroxymethyltransferase (SHMT1), abolishes migration. Using rescue experiments with a brain extracellular extract, and direct measurements, we demonstrate that cytosolic serine starvation controls cell movement by increasing reactive oxygen species formation and decreasing ATP levels, thereby promoting activation of the AMP sensor kinase (AMPK) by phosphorylation. Activation of AMPK induces remodeling of the cytoskeleton and finally controls cell motility. These results highlight that cytosolic serine metabolism plays a key role in controlling motility, suggesting that cells are able to dynamically exploit the compartmentalization of this metabolism to adapt their metabolic needs to different cell functions (movement vs. proliferation). We propose a model to explain the relevance of serine/glycine metabolism in the preferential colonization of the brain by LUAD cells and suggest that the inhibition of serine/glycine uptake and/or cytosolic SHMT1 might represent a successful strategy to limit the formation of brain metastasis from primary tumors, a major cause of death in these patients.


2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Jiaqian Xu ◽  
Haoyan Guo ◽  
Zhengcao Xing ◽  
Wenlong Zhang ◽  
Jianli He ◽  
...  

Nuclear factor erythroid 2-related factor 2 (NRF2) is a crucial transcription factor for cell adaptation and defense against oxidative stress. NRF2 activation confers Kras/Lkb1/Keap1 (KLK) mutant tumor cells with greater resistance to oxidative insults. We previously reported that SUMOylation at lysine residue 110 is important for the ability of NRF2 to promote reactive oxygen species (ROS) clearance in hepatocellular carcinoma. In this study, we investigated whether SUMOylation is necessary for the ability of NRF2 to inhibit KLK lung adenocarcinoma (LUAD) cell migration and invasion. Our experiments showed that mild oxidative stress reduced NRF2 SUMOylation, which promoted KLK LUAD cell migration and invasion. Mechanistically, NRF2 SUMOylation increased the antioxidant ability of NRF2 and reduced cellular ROS levels, mainly by transcriptionally activating Cat in KLK LUAD cells. With reduced NRF2 SUMOylation, increased ROS acted as signaling molecules to activate the JNK/c-Jun axis, which enhanced cell mobility and cell adhesion, to promote LUAD cell migration and invasion. Taken together, the results of this study reveal a novel signaling process in which reduced NRF2 SUMOylation permits increased KLK LUAD cell migration and invasion under mild oxidative stress.


Oncogene ◽  
2019 ◽  
Vol 38 (46) ◽  
pp. 7146-7165 ◽  
Author(s):  
Laura Moreno Leon ◽  
Marine Gautier ◽  
Richard Allan ◽  
Marius Ilié ◽  
Nicolas Nottet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document